# Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip

> **NCT06678724** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Head and Neck Cancers- Squamous Cell
- Head and Neck Cancer Metastatic
- Recurrent Head and Neck Squamous Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06678724
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678724, "Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06678724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*